| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | complement component C1q complex binding | 5.68e-05 | 10 | 23 | 2 | GO:0001849 | |
| GeneOntologyMolecularFunction | opsonin binding | 3.75e-04 | 25 | 23 | 2 | GO:0001846 | |
| GeneOntologyMolecularFunction | cadherin binding | 5.60e-04 | 339 | 23 | 4 | GO:0045296 | |
| GeneOntologyMolecularFunction | complement binding | 6.16e-04 | 32 | 23 | 2 | GO:0001848 | |
| GeneOntologyBiologicalProcess | positive regulation of apoptotic cell clearance | 3.62e-05 | 8 | 24 | 2 | GO:2000427 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic cell clearance | 5.81e-05 | 10 | 24 | 2 | GO:2000425 | |
| GeneOntologyBiologicalProcess | response to corticosterone | 1.96e-04 | 18 | 24 | 2 | GO:0051412 | |
| GeneOntologyCellularComponent | symbiont cell surface | 3.23e-05 | 8 | 23 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 4.15e-05 | 9 | 23 | 2 | GO:0044217 | |
| Domain | Anaphylatoxin_comp_syst | 1.58e-05 | 5 | 24 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.58e-05 | 5 | 24 | 2 | IPR001840 | |
| Domain | ANATO | 3.31e-05 | 7 | 24 | 2 | SM00104 | |
| Domain | ANAPHYLATOXIN_2 | 3.31e-05 | 7 | 24 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 3.31e-05 | 7 | 24 | 2 | PS01177 | |
| Domain | ANATO | 3.31e-05 | 7 | 24 | 2 | PF01821 | |
| Domain | Anaphylatoxin/fibulin | 3.31e-05 | 7 | 24 | 2 | IPR000020 | |
| Domain | MacrogloblnA2_CS | 4.41e-05 | 8 | 24 | 2 | IPR019742 | |
| Domain | Thiol-ester_cl | 4.41e-05 | 8 | 24 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 4.41e-05 | 8 | 24 | 2 | IPR019565 | |
| Domain | AP-1 | 5.67e-05 | 9 | 24 | 2 | IPR000837 | |
| Domain | A2M_N | 7.08e-05 | 10 | 24 | 2 | PF01835 | |
| Domain | A2M_N_2 | 7.08e-05 | 10 | 24 | 2 | PF07703 | |
| Domain | A2M_N | 7.08e-05 | 10 | 24 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 7.08e-05 | 10 | 24 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 7.08e-05 | 10 | 24 | 2 | PS00477 | |
| Domain | A2M_recep | 7.08e-05 | 10 | 24 | 2 | PF07677 | |
| Domain | A2M_comp | 7.08e-05 | 10 | 24 | 2 | PF07678 | |
| Domain | A2M | 7.08e-05 | 10 | 24 | 2 | PF00207 | |
| Domain | A2M_N_2 | 7.08e-05 | 10 | 24 | 2 | IPR011625 | |
| Domain | A2M_comp | 7.08e-05 | 10 | 24 | 2 | IPR011626 | |
| Domain | Macroglobln_a2 | 7.08e-05 | 10 | 24 | 2 | IPR001599 | |
| Domain | bZIP_2 | 2.13e-04 | 17 | 24 | 2 | PF07716 | |
| Domain | C345C | 2.13e-04 | 17 | 24 | 2 | SM00643 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 2.39e-04 | 18 | 24 | 2 | IPR008930 | |
| Domain | NTR | 2.67e-04 | 19 | 24 | 2 | PF01759 | |
| Domain | Netrin_module_non-TIMP | 2.67e-04 | 19 | 24 | 2 | IPR018933 | |
| Domain | Netrin_domain | 3.94e-04 | 23 | 24 | 2 | IPR001134 | |
| Domain | NTR | 3.94e-04 | 23 | 24 | 2 | PS50189 | |
| Domain | TIMP-like_OB-fold | 5.05e-04 | 26 | 24 | 2 | IPR008993 | |
| Domain | Spectrin_repeat | 6.29e-04 | 29 | 24 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 7.67e-04 | 32 | 24 | 2 | IPR018159 | |
| Domain | SPEC | 7.67e-04 | 32 | 24 | 2 | SM00150 | |
| Domain | bZIP_1 | 8.66e-04 | 34 | 24 | 2 | PF00170 | |
| Domain | TF_DNA-bd | 1.03e-03 | 37 | 24 | 2 | IPR008917 | |
| Domain | BRLZ | 2.02e-03 | 52 | 24 | 2 | SM00338 | |
| Domain | BZIP | 2.10e-03 | 53 | 24 | 2 | PS50217 | |
| Domain | BZIP_BASIC | 2.10e-03 | 53 | 24 | 2 | PS00036 | |
| Domain | bZIP | 2.17e-03 | 54 | 24 | 2 | IPR004827 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 4.86e-05 | 7 | 22 | 2 | MM14685 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 6.17e-05 | 50 | 22 | 3 | M48087 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 6.47e-05 | 8 | 22 | 2 | M27031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 6.47e-05 | 8 | 22 | 2 | M47872 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.27e-04 | 11 | 22 | 2 | MM1430 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 1.27e-04 | 11 | 22 | 2 | M47874 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 1.52e-04 | 12 | 22 | 2 | MM1368 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 1.79e-04 | 13 | 22 | 2 | M4732 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 2.41e-04 | 15 | 22 | 2 | M7146 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 3.12e-04 | 17 | 22 | 2 | MM15944 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 3.12e-04 | 17 | 22 | 2 | MM1369 | |
| Pathway | BIOCARTA_COMP_PATHWAY | 4.34e-04 | 20 | 22 | 2 | M917 | |
| Pathway | WP_COMPLEMENT_ACTIVATION | 5.27e-04 | 22 | 22 | 2 | M39502 | |
| Pathway | WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION | 1.19e-03 | 33 | 22 | 2 | M39909 | |
| Pathway | REACTOME_NGF_STIMULATED_TRANSCRIPTION | 1.66e-03 | 39 | 22 | 2 | M29793 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 9.89e-10 | 497 | 24 | 8 | 36774506 | |
| Pubmed | 2.02e-07 | 650 | 24 | 7 | 38777146 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 4.56e-07 | 2 | 24 | 2 | 16565498 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 15998580 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 4.56e-07 | 2 | 24 | 2 | 25339671 | |
| Pubmed | Sleep and wakefulness in c-fos and fos B gene knockout mice. | 4.56e-07 | 2 | 24 | 2 | 11039731 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 17728371 | ||
| Pubmed | Forebrain patterns of c-Fos and FosB induction during cancer-associated anorexia-cachexia in rat. | 4.56e-07 | 2 | 24 | 2 | 15926923 | |
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 4.56e-07 | 2 | 24 | 2 | 7373044 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 4.56e-07 | 2 | 24 | 2 | 3696167 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 17482371 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6149580 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6149581 | ||
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 4.56e-07 | 2 | 24 | 2 | 1357031 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 32482537 | ||
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 4.56e-07 | 2 | 24 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 4.56e-07 | 2 | 24 | 2 | 19933335 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 12115608 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 3542363 | ||
| Pubmed | Recurrent rearrangements of FOS and FOSB define osteoblastoma. | 4.56e-07 | 2 | 24 | 2 | 29858576 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 2387317 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 8132550 | ||
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 4.56e-07 | 2 | 24 | 2 | 2459207 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 36008878 | ||
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 4.56e-07 | 2 | 24 | 2 | 17645767 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 16263220 | ||
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 4.56e-07 | 2 | 24 | 2 | 15787745 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 12207352 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 2395880 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 26814708 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6192448 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6167582 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 16908004 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 30026462 | ||
| Pubmed | Expression of FosB during mouse development: normal development of FosB knockout mice. | 4.56e-07 | 2 | 24 | 2 | 8668344 | |
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 4.56e-07 | 2 | 24 | 2 | 1438267 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 7365238 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 4.56e-07 | 2 | 24 | 2 | 27758680 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 19150565 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 7391573 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 17506029 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 22387014 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 17971360 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 4.56e-07 | 2 | 24 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 4.56e-07 | 2 | 24 | 2 | 20506482 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 23715124 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 3464002 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 2993295 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 37461273 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 4.56e-07 | 2 | 24 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 4.56e-07 | 2 | 24 | 2 | 17971229 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 12480675 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6881182 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 4.56e-07 | 2 | 24 | 2 | 23749435 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 23918728 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 4.56e-07 | 2 | 24 | 2 | 3944109 | |
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 4.56e-07 | 2 | 24 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 4.56e-07 | 2 | 24 | 2 | 3037333 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 37553246 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 11726230 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 4216347 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 4.56e-07 | 2 | 24 | 2 | 17921792 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 21880985 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 4.56e-07 | 2 | 24 | 2 | 1699796 | |
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 4.56e-07 | 2 | 24 | 2 | 6978711 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 4.56e-07 | 2 | 24 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 4.56e-07 | 2 | 24 | 2 | 2997024 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 35898513 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 33353966 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 3008092 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 4.56e-07 | 2 | 24 | 2 | 3624865 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 28873507 | ||
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 4.56e-07 | 2 | 24 | 2 | 8428773 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 21857912 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6609966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 4.56e-07 | 2 | 24 | 2 | 2900855 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 24638111 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 4.56e-07 | 2 | 24 | 2 | 4514997 | |
| Pubmed | Fos family members induce cell cycle entry by activating cyclin D1. | 4.56e-07 | 2 | 24 | 2 | 9710644 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 12376177 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 276882 | ||
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 4.56e-07 | 2 | 24 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 4.56e-07 | 2 | 24 | 2 | 5919331 | |
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 4.56e-07 | 2 | 24 | 2 | 6832377 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 4.56e-07 | 2 | 24 | 2 | 3167981 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 3794341 | ||
| Pubmed | Complement and c4 null alleles in severe chronic adult periodontitis. | 4.56e-07 | 2 | 24 | 2 | 17257223 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 2272665 | ||
| Pubmed | Multiple C4/Slp genes distinguished by expression after transfection. | 4.56e-07 | 2 | 24 | 2 | 3023818 | |
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 7545960 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 30041577 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 2572548 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 22785613 | ||
| Pubmed | 4.56e-07 | 2 | 24 | 2 | 2302180 | ||
| Interaction | FBXO22 interactions | 1.27e-07 | 540 | 24 | 8 | int:FBXO22 | |
| GeneFamily | Basic leucine zipper proteins|Fos transcription factor family | 4.99e-06 | 4 | 17 | 2 | 1256 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.98e-05 | 9 | 17 | 2 | 1234 | |
| GeneFamily | Complement system|Sushi domain containing | 5.14e-04 | 36 | 17 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 5.44e-04 | 37 | 17 | 2 | 454 | |
| GeneFamily | Basic leucine zipper proteins | 9.53e-04 | 49 | 17 | 2 | 506 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 4.20e-06 | 272 | 24 | 5 | MM3825 | |
| Coexpression | WHITFIELD_CELL_CYCLE_M_G1 | 5.02e-06 | 126 | 24 | 4 | M2078 | |
| Coexpression | CROONQUIST_STROMAL_STIMULATION_UP | 1.81e-05 | 56 | 24 | 3 | M5929 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 2.87e-05 | 196 | 24 | 4 | MM3746 | |
| Coexpression | CHASSOT_SKIN_WOUND | 2.88e-05 | 9 | 24 | 2 | M13038 | |
| Coexpression | LEE_AGING_NEOCORTEX_UP | 5.91e-05 | 83 | 24 | 3 | MM1022 | |
| Coexpression | LEE_AGING_CEREBELLUM_UP | 6.80e-05 | 87 | 24 | 3 | MM1023 | |
| Coexpression | MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 7.26e-05 | 14 | 24 | 2 | M1931 | |
| Coexpression | MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 7.26e-05 | 14 | 24 | 2 | MM816 | |
| Coexpression | ROVERSI_GLIOMA_COPY_NUMBER_UP | 1.03e-04 | 100 | 24 | 3 | M11028 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_DN | 1.40e-04 | 111 | 24 | 3 | MM1111 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_BASAL_CELL_AGEING | 1.96e-04 | 322 | 24 | 4 | MM3786 | |
| Coexpression | MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED | 2.01e-04 | 23 | 24 | 2 | M1937 | |
| Coexpression | MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED | 2.01e-04 | 23 | 24 | 2 | MM821 | |
| Coexpression | EPPERT_HSC_R | 2.09e-04 | 127 | 24 | 3 | M19231 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_LEUKOCYTE_AGEING | 2.39e-04 | 133 | 24 | 3 | MM3715 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_STROMAL_CELL_AGEING | 2.66e-04 | 349 | 24 | 4 | MM3790 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP | 3.34e-04 | 149 | 24 | 3 | M8786 | |
| Coexpression | GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS | 3.54e-04 | 152 | 24 | 3 | M43614 | |
| Coexpression | AMIT_SERUM_RESPONSE_40_MCF10A | 3.92e-04 | 32 | 24 | 2 | M11519 | |
| Coexpression | TARTE_PLASMA_CELL_VS_PLASMABLAST_UP | 4.37e-04 | 398 | 24 | 4 | M4872 | |
| Coexpression | NAGASHIMA_NRG1_SIGNALING_UP | 5.08e-04 | 172 | 24 | 3 | M11585 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP | 5.25e-04 | 174 | 24 | 3 | M2038 | |
| Coexpression | GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP | 5.34e-04 | 175 | 24 | 3 | M6343 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 5.52e-04 | 177 | 24 | 3 | M39245 | |
| Coexpression | CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP | 5.83e-04 | 39 | 24 | 2 | M13339 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FIBROBLAST_AGEING | 5.83e-04 | 39 | 24 | 2 | MM3721 | |
| Coexpression | PEREZ_TP53_TARGETS | 6.04e-04 | 1201 | 24 | 6 | M4391 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN | 6.89e-04 | 191 | 24 | 3 | M8802 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 7.21e-04 | 194 | 24 | 3 | M39122 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN | 7.31e-04 | 195 | 24 | 3 | M4292 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP | 7.53e-04 | 197 | 24 | 3 | M5295 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP | 7.64e-04 | 198 | 24 | 3 | M5293 | |
| Coexpression | GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP | 7.76e-04 | 199 | 24 | 3 | M7252 | |
| Coexpression | KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN | 7.76e-04 | 199 | 24 | 3 | M3028 | |
| Coexpression | GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP | 7.87e-04 | 200 | 24 | 3 | M9023 | |
| Coexpression | GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN | 7.87e-04 | 200 | 24 | 3 | M3714 | |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN | 7.87e-04 | 200 | 24 | 3 | M5078 | |
| Coexpression | GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN | 7.87e-04 | 200 | 24 | 3 | M9079 | |
| Coexpression | GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN | 7.87e-04 | 200 | 24 | 3 | M9901 | |
| Coexpression | GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP | 7.87e-04 | 200 | 24 | 3 | M7661 | |
| Coexpression | GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN | 7.87e-04 | 200 | 24 | 3 | M5841 | |
| Coexpression | GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN | 7.87e-04 | 200 | 24 | 3 | M5837 | |
| Coexpression | GSE17721_LPS_VS_CPG_2H_BMDC_UP | 7.87e-04 | 200 | 24 | 3 | M3989 | |
| Coexpression | GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP | 7.87e-04 | 200 | 24 | 3 | M3038 | |
| Coexpression | GSE10325_BCELL_VS_MYELOID_DN | 7.87e-04 | 200 | 24 | 3 | M3082 | |
| Coexpression | GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP | 7.87e-04 | 200 | 24 | 3 | M9624 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_2HR | 8.11e-04 | 46 | 24 | 2 | MM1184 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_2HR | 8.11e-04 | 46 | 24 | 2 | M1597 | |
| Coexpression | CHIBA_RESPONSE_TO_TSA_UP | 9.58e-04 | 50 | 24 | 2 | M10372 | |
| Coexpression | LUI_THYROID_CANCER_CLUSTER_1 | 1.04e-03 | 52 | 24 | 2 | M2135 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP | 1.09e-03 | 224 | 24 | 3 | M12383 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_COMPLETE | 1.09e-03 | 224 | 24 | 3 | M2500 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | 1.10e-03 | 888 | 24 | 5 | M39049 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 1.16e-03 | 229 | 24 | 3 | MM16607 | |
| Coexpression | FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL | 1.21e-03 | 232 | 24 | 3 | M41718 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.22e-03 | 233 | 24 | 3 | M13273 | |
| Coexpression | NAGASHIMA_EGF_SIGNALING_UP | 1.24e-03 | 57 | 24 | 2 | M16311 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING | 1.24e-03 | 57 | 24 | 2 | MM3716 | |
| Coexpression | HALLMARK_MYC_TARGETS_V2 | 1.29e-03 | 58 | 24 | 2 | M5928 | |
| Coexpression | LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET | 1.33e-03 | 240 | 24 | 3 | M39236 | |
| Coexpression | BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS | 1.38e-03 | 60 | 24 | 2 | M40007 | |
| Coexpression | LEE_TARGETS_OF_PTCH1_AND_SUFU_UP | 1.38e-03 | 60 | 24 | 2 | MM601 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 1.38e-03 | 60 | 24 | 2 | MM654 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 1.40e-03 | 244 | 24 | 3 | MM3706 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#4_top-relative-expression-ranked_100 | 1.22e-06 | 2 | 24 | 2 | gudmap_developingKidney_e15.5_Endothelial cells_100_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_200 | 3.67e-06 | 3 | 24 | 2 | gudmap_developingKidney_e15.5_Endothelial cells_200_k5 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#2_top-relative-expression-ranked_100 | 7.34e-06 | 4 | 24 | 2 | gudmap_developingKidney_e11.5_ureteric bud_100_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_500 | 2.55e-05 | 51 | 24 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k1 | |
| CoexpressionAtlas | DevelopingKidney_e11.5_ureteric bud_emap-3844_k-means-cluster#1_top-relative-expression-ranked_200 | 3.41e-05 | 8 | 24 | 2 | gudmap_developingKidney_e11.5_ureteric bud_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#2_top-relative-expression-ranked_100 | 6.69e-05 | 11 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_100_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#1_top-relative-expression-ranked_500 | 8.02e-05 | 12 | 24 | 2 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#1_top-relative-expression-ranked_100 | 8.02e-05 | 12 | 24 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_100_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_100 | 9.13e-05 | 78 | 24 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#2_top-relative-expression-ranked_100 | 9.48e-05 | 13 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100_k2 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.26e-04 | 87 | 24 | 3 | GSM777050_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#4_top-relative-expression-ranked_200 | 1.27e-04 | 15 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_200_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_200 | 1.46e-04 | 16 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#3_top-relative-expression-ranked_500 | 1.46e-04 | 16 | 24 | 2 | gudmap_developingKidney_e15.5_Endothelial cells_500_k3 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 1.50e-04 | 466 | 24 | 5 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#1_top-relative-expression-ranked_200 | 2.79e-04 | 22 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_100 | 3.91e-04 | 26 | 24 | 2 | gudmap_developingGonad_e18.5_epididymis_100_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_ReproVasc_Flk_k-means-cluster#1_top-relative-expression-ranked_500 | 4.88e-04 | 29 | 24 | 2 | gudmap_dev gonad_e11.5_F_ReproVasc_Flk_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#4_top-relative-expression-ranked_200 | 5.58e-04 | 31 | 24 | 2 | gudmap_developingKidney_e15.5_Cap mesenchyme_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_200 | 6.72e-04 | 34 | 24 | 2 | gudmap_developingGonad_e16.5_epididymis_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_200 | 7.43e-04 | 159 | 24 | 3 | gudmap_developingKidney_e15.5_Endothelial cells_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_200 | 7.56e-04 | 160 | 24 | 3 | gudmap_developingKidney_e15.5_Cap mesenchyme_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_500 | 9.87e-04 | 401 | 24 | 4 | gudmap_developingKidney_e15.5_Cap mesenchyme_500 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.59e-06 | 161 | 24 | 4 | be77e99faf653480c166305df3a4e93db76f0dcb | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.61e-06 | 198 | 24 | 4 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte|COVID-19_Convalescent / Disease condition and Cell class | 7.76e-06 | 72 | 24 | 3 | 73db21be480920fc936f3a965495f5cf004e350a | |
| ToppCell | NS-moderate-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.56e-05 | 130 | 24 | 3 | 1491e8975520e99c527a5b5bee64875d124f7bf4 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.58e-05 | 147 | 24 | 3 | 27e97a7b1dc296f52990b5810a52ab0a7ef2b9e6 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.84e-05 | 156 | 24 | 3 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | -Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 7.84e-05 | 156 | 24 | 3 | f0c4d9d58365b0ae8e10ba1aaf3847fb3f98c7ad | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.84e-05 | 156 | 24 | 3 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.30e-05 | 159 | 24 | 3 | 655c0749c238bd68cb797adb83e25a23b8a3cc9d | |
| ToppCell | 343B-Myeloid-Mast_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-05 | 160 | 24 | 3 | a2f09b5955602819c8978f4372130c8ef915cd07 | |
| ToppCell | 343B-Myeloid-Mast_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-05 | 160 | 24 | 3 | 133ecae0a894d9a0d49d58859623359096b6f030 | |
| ToppCell | droplet-Fat-Scat-21m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-05 | 165 | 24 | 3 | 3f0c2486ea357d10dad0b703cf75cc29bdd5b5cf | |
| ToppCell | 343B-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-05 | 166 | 24 | 3 | 4e47e7f3019fb2dcbc35b4e9b47ee265a97cec5c | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.43e-05 | 166 | 24 | 3 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | 343B-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.43e-05 | 166 | 24 | 3 | f6e2ec767c022982ef416fadb998a7b6b958f76a | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.60e-05 | 167 | 24 | 3 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization) | 9.60e-05 | 167 | 24 | 3 | 7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.77e-05 | 168 | 24 | 3 | d2b91f2adc95dcfa623f8d7ca2df1c6f884da988 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-04 | 171 | 24 | 3 | 48125d825ca2d7ef34564250f5b47d2a579e03c9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.03e-04 | 171 | 24 | 3 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 172 | 24 | 3 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.14e-04 | 177 | 24 | 3 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | AT1_cells-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 180 | 24 | 3 | ff4728782c3ec814ba071cc22b7894abdd9da837 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 24 | 3 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 24 | 3 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 182 | 24 | 3 | 9ba85f621a846531a2a7861e9df695d288c9e149 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 24 | 3 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 184 | 24 | 3 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 184 | 24 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-04 | 185 | 24 | 3 | d42f6722a6771752cd744146a09e2ead9b7252bc | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 185 | 24 | 3 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 1.30e-04 | 185 | 24 | 3 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 1.30e-04 | 185 | 24 | 3 | b8cd94cf18308b514fc61557550225794ffd2860 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_mesenchymal_cell_(Scara5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 187 | 24 | 3 | 7beba2a5d5978f2ae7d8bde10815705cf2572211 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 1.34e-04 | 187 | 24 | 3 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.34e-04 | 187 | 24 | 3 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 24 | 3 | 5e13725136114e42d3b59647cf25e0f3c53abb54 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-04 | 188 | 24 | 3 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.36e-04 | 188 | 24 | 3 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 189 | 24 | 3 | 7c6d586f352d0d44c24079e76272cb3a545441b5 | |
| ToppCell | droplet-Fat-SCAT-30m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 189 | 24 | 3 | 8161910a19089f8cc5a3f1fda039f41a2488f04f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 1.38e-04 | 189 | 24 | 3 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | droplet-Fat-SCAT|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 189 | 24 | 3 | 264c59de2adb8bee5bb57633d79d530a8829617b | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 189 | 24 | 3 | 5438baaa3056fec46d59f75f03f27a93601936c1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | dc7e92f1b18d0f5efec11d09d56ba954d4f8b3bd | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 0bb06df3d5a50416854370f234718c6cec3d773b | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 190 | 24 | 3 | b7aafb4393d9b9e3e57411c096afb51dab2b0002 | |
| ToppCell | facs-SCAT-Fat-24m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 008290bb5c79446681dd6bf354336c57ad0d6f13 | |
| ToppCell | (1)_Control_(PBS)-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 1.41e-04 | 190 | 24 | 3 | ec0ab31266583a0966ac7615d5c0fabb7b7e66e8 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | 1efb47743b6834b64cb0f61721ddbe875b1a66ca | |
| ToppCell | (1)_Control_(PBS)|World / Stress and Cell class | 1.43e-04 | 191 | 24 | 3 | b346e13259cb2d506b923ad44b894c21a3eee4c3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 24 | 3 | 2c51850f5c559d665b8a27a12b75af9ed58dffe1 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | c47df468cf78a90929913c9022e8078a53cdf680 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-04 | 192 | 24 | 3 | 930319cbd82b9e54864147ffcdc8bd0ea7b937be | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | 5e6f8206ee0b10cdba79a7c4a05452cb025a5512 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 192 | 24 | 3 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.45e-04 | 192 | 24 | 3 | c7bcebcb88a25b2c97d798120efa9d5958e7f798 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.45e-04 | 192 | 24 | 3 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 192 | 24 | 3 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 192 | 24 | 3 | 3f925a80b5e2b0577d573e88598a2984a5f6a789 | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 192 | 24 | 3 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-04 | 192 | 24 | 3 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 192 | 24 | 3 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | droplet-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | e55f79bad6888b84b0ad5fccded498b170e3c6dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 193 | 24 | 3 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | eb3c46b6fb06dc8708dc3032189b47ed93ee2357 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.47e-04 | 193 | 24 | 3 | dbf0fe496254320c894568c31e5f9ce63707d1b5 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 193 | 24 | 3 | b45cd02081f97904eaea2d013e1fa980505d060b | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 194 | 24 | 3 | b294056f9bdc243263cf36dce7b62564144b9de1 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-04 | 194 | 24 | 3 | 1a188e52f2f0b6eca3e8d4a4671d9beab0fbbb88 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 194 | 24 | 3 | ee6b5fb4e993a4c0dc556091b8fefd56bdc70d8f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-04 | 194 | 24 | 3 | 889c6e231bdd5b59902c7d2afdc077360b1d3256 | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|World / Lineage and Cell class | 1.52e-04 | 195 | 24 | 3 | 69723b06c2a5c2aaf4d10874b11bca7f06822bdc | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | c54b19e31efe2c9ae690062569da7c0f1120a1d8 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 195 | 24 | 3 | 3365768101454060b9ea96ef6b426c76c150bc8f | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 195 | 24 | 3 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 3e4f9ecfaa756386d816a26313b7229ec092d4e6 | |
| ToppCell | facs-Trachea-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 195 | 24 | 3 | 0d1876f6fdc1eafeb60d6fd7da5bce737d2b4a5a | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 196 | 24 | 3 | 27a216af92100224818c91e298428bee25ab0af8 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 196 | 24 | 3 | 847b3377f463bfded046eec63cc1b547f3dc33c1 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 196 | 24 | 3 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 196 | 24 | 3 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | droplet-Kidney-nan-3m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 196 | 24 | 3 | b880c9665d42c76ea1971d4e49d7ecf72fcfafb6 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-bladder_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 196 | 24 | 3 | 83669ffdfe663885086571ccb0809f62aaba9752 | |
| ToppCell | (0)_Myeloid-(000)_CD14+_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 1.54e-04 | 196 | 24 | 3 | e9718642ee2751c9d46a1b968547bdcb59cdfd30 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | d624f3a105b19f19a0dd253ce8de3ed13adc1f01 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.56e-04 | 197 | 24 | 3 | 6e96a6c2576f52b72aeab1e41f47a0af05ff327a | |
| ToppCell | BLOOD--(3)_MNP-(3)_Classical_Mono-2|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.56e-04 | 197 | 24 | 3 | 330dc70395658dee4d04ac4930d9ce7aa8a083f4 | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-late-42|World / Primary Cells by Cluster | 1.56e-04 | 197 | 24 | 3 | 0057aa4bce8684711b061710eab1d2b85e14e055 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 197 | 24 | 3 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-04 | 197 | 24 | 3 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-04 | 197 | 24 | 3 | a80be1081f3ed0aceea69a33be21bca6bc354472 | |
| ToppCell | mLN-T_cell-Th1|T_cell / Region, Cell class and subclass | 1.56e-04 | 197 | 24 | 3 | 5e39a49dddef04469ff2b615d755ddf6a926e58e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | 2a90422ba400b951517603a916f34221056d0f3d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.56e-04 | 197 | 24 | 3 | 928d70af7b990300be69a4debce6e66b556e5d9f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.56e-04 | 197 | 24 | 3 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| Computational | Complement. | 3.92e-04 | 23 | 14 | 2 | MODULE_130 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_MEMORY_NAIVE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS | |
| Drug | Chlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.63e-06 | 195 | 24 | 5 | 1700_DN | |
| Drug | W-13, hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 1.85e-06 | 200 | 24 | 5 | 643_DN | |
| Drug | 2-aminothiophenol | 3.19e-06 | 3 | 24 | 2 | ctd:C005464 | |
| Drug | N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine | 6.38e-06 | 4 | 24 | 2 | ctd:C478058 | |
| Drug | canventol | 1.06e-05 | 5 | 24 | 2 | CID000073256 | |
| Drug | RG 12525 | 1.06e-05 | 5 | 24 | 2 | CID000129044 | |
| Drug | pyro-Glu-His-Gly | 1.59e-05 | 6 | 24 | 2 | CID003918406 | |
| Drug | AC1L4GYE | 1.59e-05 | 6 | 24 | 2 | CID000156861 | |
| Drug | APDC | 1.76e-05 | 318 | 24 | 5 | CID000065351 | |
| Drug | AC1MI4R0 | 2.23e-05 | 7 | 24 | 2 | CID003038396 | |
| Drug | 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone | 3.56e-05 | 61 | 24 | 3 | ctd:C517943 | |
| Drug | N-((2,2-dimethyl-2,3-dihydrobenzofuran-7-yloxy)ethyl)-3-(cyclopent-1-enyl)benzylamine | 3.82e-05 | 9 | 24 | 2 | ctd:C518313 | |
| Drug | iododimethylarsine | 3.82e-05 | 9 | 24 | 2 | CID000069608 | |
| Drug | tilisolol | 3.82e-05 | 9 | 24 | 2 | CID000005474 | |
| Drug | N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea | 3.82e-05 | 9 | 24 | 2 | ctd:C092756 | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.85e-05 | 195 | 24 | 4 | 7435_UP | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 4.85e-05 | 195 | 24 | 4 | 3278_UP | |
| Drug | Halofantrine hydrochloride [36167-63-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 4.85e-05 | 195 | 24 | 4 | 7469_UP | |
| Drug | aldosterone | 5.08e-05 | 397 | 24 | 5 | CID000005839 | |
| Drug | 4-O-methyl-12-O-tetradecanoylphorbol 13-acetate | 6.98e-05 | 12 | 24 | 2 | ctd:C020922 | |
| Drug | B-VL | 8.25e-05 | 13 | 24 | 2 | CID005321765 | |
| Drug | methyloxoarsine | 9.62e-05 | 14 | 24 | 2 | CID000092815 | |
| Drug | CY 208-243 | 9.62e-05 | 14 | 24 | 2 | CID000058144 | |
| Drug | CT 0 | 1.11e-04 | 15 | 24 | 2 | CID002255489 | |
| Drug | 1h08 | 1.11e-04 | 15 | 24 | 2 | CID000445957 | |
| Drug | vinylene | 1.17e-04 | 245 | 24 | 4 | CID000006326 | |
| Drug | AC1L4IJB | 1.27e-04 | 16 | 24 | 2 | CID000157710 | |
| Drug | N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide | 1.43e-04 | 17 | 24 | 2 | ctd:C090413 | |
| Drug | copper fluoride | 1.43e-04 | 17 | 24 | 2 | CID000082236 | |
| Drug | SR-202 | 1.43e-04 | 17 | 24 | 2 | CID000060910 | |
| Drug | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1.80e-04 | 19 | 24 | 2 | ctd:D017371 | |
| Drug | angiotensin | 2.01e-04 | 282 | 24 | 4 | CID003083715 | |
| Drug | mercury | 2.19e-04 | 542 | 24 | 5 | CID000023931 | |
| Drug | Bi-O | 2.21e-04 | 21 | 24 | 2 | CID005287844 | |
| Drug | 4-nitroquinoline | 2.21e-04 | 21 | 24 | 2 | CID000077341 | |
| Drug | Silver Nitrate | 2.60e-04 | 119 | 24 | 3 | ctd:D012835 | |
| Drug | olanzapine | 2.73e-04 | 121 | 24 | 3 | ctd:C076029 | |
| Drug | Antigen-Antibody Complex | 2.90e-04 | 24 | 24 | 2 | ctd:D000936 | |
| Drug | SB204741 | 2.90e-04 | 24 | 24 | 2 | CID003277600 | |
| Drug | APTS | 2.90e-04 | 24 | 24 | 2 | CID004346575 | |
| Drug | cyclopentenone | 3.08e-04 | 126 | 24 | 3 | CID000013588 | |
| Drug | SL 327 | 3.15e-04 | 25 | 24 | 2 | ctd:C424127 | |
| Drug | 6-methyl-2-(phenylethynyl)pyridine | 3.15e-04 | 25 | 24 | 2 | ctd:C121465 | |
| Drug | delta-tocopherol | 3.41e-04 | 26 | 24 | 2 | ctd:C479072 | |
| Drug | inulin | 3.61e-04 | 133 | 24 | 3 | CID000024763 | |
| Drug | Eprosartan-d3 | 3.96e-04 | 28 | 24 | 2 | CID000060878 | |
| Drug | aptiganel | 3.96e-04 | 28 | 24 | 2 | CID000060839 | |
| Drug | MCDF | 3.96e-04 | 28 | 24 | 2 | CID000114900 | |
| Drug | 6-sulfatoxymelatonin | 4.25e-04 | 29 | 24 | 2 | CID000065096 | |
| Drug | dibutyldichlorotin | 4.55e-04 | 30 | 24 | 2 | ctd:C020735 | |
| Drug | mg U | 4.55e-04 | 30 | 24 | 2 | CID000445508 | |
| Drug | zinc borate | 5.18e-04 | 32 | 24 | 2 | CID000159268 | |
| Drug | RU 24969 | 5.18e-04 | 32 | 24 | 2 | CID000108028 | |
| Drug | 8-oxoG | 5.18e-04 | 32 | 24 | 2 | CID000065131 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 6.07e-04 | 159 | 24 | 3 | 4328_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; HL60; HT_HG-U133A | 6.18e-04 | 160 | 24 | 3 | 2429_UP | |
| Drug | NSC305787 | 6.20e-04 | 35 | 24 | 2 | ctd:C570896 | |
| Drug | Pyr-his-gly | 6.20e-04 | 35 | 24 | 2 | CID000122313 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 6.41e-04 | 162 | 24 | 3 | 3771_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; HL60; HT_HG-U133A | 6.53e-04 | 163 | 24 | 3 | 2145_UP | |
| Drug | gamma-Tocopherol | 6.56e-04 | 36 | 24 | 2 | ctd:D024504 | |
| Drug | vasopressin | 6.74e-04 | 388 | 24 | 4 | CID011979316 | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 6.88e-04 | 166 | 24 | 3 | 5826_UP | |
| Drug | CT 6 | 6.93e-04 | 37 | 24 | 2 | CID005327130 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; PC3; HT_HG-U133A | 7.00e-04 | 167 | 24 | 3 | 6680_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.13e-04 | 168 | 24 | 3 | 6820_DN | |
| Drug | fosphomycin | 7.31e-04 | 38 | 24 | 2 | CID000003417 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 7.63e-04 | 172 | 24 | 3 | 3979_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.63e-04 | 172 | 24 | 3 | 7073_DN | |
| Drug | Parthenolide [20554-84-1]; Up 200; 16.2uM; PC3; HT_HG-U133A | 7.76e-04 | 173 | 24 | 3 | 5105_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.89e-04 | 174 | 24 | 3 | 5693_DN | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 8.16e-04 | 176 | 24 | 3 | 4827_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 8.43e-04 | 178 | 24 | 3 | 4184_DN | |
| Drug | ginsenoside Rb1 | 8.52e-04 | 41 | 24 | 2 | CID000073148 | |
| Drug | AC1L1BK6 | 8.52e-04 | 41 | 24 | 2 | CID000001473 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; PC3; HT_HG-U133A | 8.56e-04 | 179 | 24 | 3 | 4541_UP | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; PC3; HT_HG-U133A | 8.56e-04 | 179 | 24 | 3 | 4085_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; PC3; HT_HG-U133A | 8.56e-04 | 179 | 24 | 3 | 4217_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.70e-04 | 180 | 24 | 3 | 6454_DN | |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Up 200; 15.4uM; PC3; HT_HG-U133A | 8.70e-04 | 180 | 24 | 3 | 7139_UP | |
| Drug | Menadione [58-27-5]; Up 200; 23.2uM; PC3; HT_HG-U133A | 8.84e-04 | 181 | 24 | 3 | 4662_UP | |
| Drug | phencyclidine | 8.84e-04 | 181 | 24 | 3 | CID000006468 | |
| Drug | AC1NUV1F | 8.94e-04 | 42 | 24 | 2 | CID005494395 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 8.99e-04 | 182 | 24 | 3 | 2321_UP | |
| Drug | Disulfiram [97-77-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 9.13e-04 | 183 | 24 | 3 | 2053_UP | |
| Drug | Methionine phosphonate | 9.37e-04 | 43 | 24 | 2 | CID000444719 | |
| Drug | WIN55212-2 | 9.81e-04 | 44 | 24 | 2 | CID000005689 | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 24 | 3 | 1483_UP | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.02e-03 | 190 | 24 | 3 | 5623_UP | |
| Drug | Phthalic Acids | 1.04e-03 | 762 | 24 | 5 | ctd:D010795 | |
| Disease | Neurotoxicity Syndromes | 2.54e-04 | 29 | 24 | 2 | C0235032 | |
| Disease | Encephalopathy, Toxic | 2.54e-04 | 29 | 24 | 2 | C0149504 | |
| Disease | Toxic Encephalitis | 2.54e-04 | 29 | 24 | 2 | C0154659 | |
| Disease | Complement deficiency disease | 3.30e-04 | 33 | 24 | 2 | C0272242 | |
| Disease | tongue squamous cell carcinoma (is_marker_for) | 4.15e-04 | 37 | 24 | 2 | DOID:0050865 (is_marker_for) | |
| Disease | Graves' disease (is_implicated_in) | 4.61e-04 | 39 | 24 | 2 | DOID:12361 (is_implicated_in) | |
| Disease | systemic lupus erythematosus (implicated_via_orthology) | 5.61e-04 | 43 | 24 | 2 | DOID:9074 (implicated_via_orthology) | |
| Disease | systemic lupus erythematosus (is_implicated_in) | 1.16e-03 | 62 | 24 | 2 | DOID:9074 (is_implicated_in) | |
| Disease | renal cell carcinoma (is_implicated_in) | 1.44e-03 | 69 | 24 | 2 | DOID:4450 (is_implicated_in) | |
| Disease | Lupus Erythematosus, Systemic | 1.52e-03 | 71 | 24 | 2 | C0024141 | |
| Disease | Awakening Epilepsy | 2.02e-03 | 82 | 24 | 2 | C0751111 | |
| Disease | Aura | 2.02e-03 | 82 | 24 | 2 | C0236018 | |
| Disease | Epilepsy, Cryptogenic | 2.02e-03 | 82 | 24 | 2 | C0086237 | |
| Disease | Epilepsy | 3.54e-03 | 109 | 24 | 2 | C0014544 | |
| Disease | Cocaine-Related Disorders | 4.06e-03 | 117 | 24 | 2 | C0236736 | |
| Disease | Cocaine Abuse | 4.77e-03 | 127 | 24 | 2 | C0009171 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 5.06e-03 | 131 | 24 | 2 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 5.06e-03 | 131 | 24 | 2 | C4552091 | |
| Disease | Juvenile arthritis | 5.06e-03 | 131 | 24 | 2 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 5.06e-03 | 131 | 24 | 2 | C3714758 | |
| Disease | Juvenile-Onset Still Disease | 5.37e-03 | 135 | 24 | 2 | C0087031 | |
| Disease | Cocaine Dependence | 5.68e-03 | 139 | 24 | 2 | C0600427 | |
| Disease | Hypertensive disease | 1.04e-02 | 190 | 24 | 2 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RRREAPKVVEEQESR | 1451 | P0C0L5 | |
| VVEIVDEKVRRREEP | 466 | Q6PKG0 | |
| QDDDKRVIAIRPIRR | 236 | Q86WA8 | |
| QLSPEEEEKRRIRRE | 131 | P01100 | |
| LRPREVQVREFEVLR | 46 | Q14164 | |
| RVRIAIKEIPERDSR | 671 | O95382 | |
| VEEQERERRRQVVEK | 736 | Q9Y2G0 | |
| RVRRAIPREDKEEIL | 46 | Q9H0B8 | |
| RTQRPLERLEEKEVV | 946 | Q92817 | |
| VEKVRGELLRERVQR | 941 | Q86UK5 | |
| TPEEEEKRRVRRERN | 151 | P53539 | |
| KEDIVRRERIGFRVQ | 46 | Q7Z7M9 | |
| EVEVPVVDRRNLRRK | 641 | Q9Y6X4 | |
| SVVRIIEREEKIDRR | 211 | O60645 | |
| RVLQKERAIEERRVV | 1531 | Q5VV67 | |
| RRREAPKVVEEQESR | 1451 | P0C0L4 | |
| VVPFVRVKREREVDE | 66 | Q53GS9 | |
| RAVREVLVRALPVEE | 771 | Q2M3G4 | |
| EVRRQQEEEERKRRP | 2086 | Q01082 | |
| PKEIQRERREVVRKI | 206 | O75829 | |
| RERREVVRKIVPTTT | 211 | O75829 | |
| RVIEEEEVVRPQRRK | 836 | Q9P2E3 | |
| QVEERRKREELQVPE | 306 | Q96IT1 | |
| RRVRVEKLQEVVRKP | 146 | A5D8V6 | |
| RVPEAVALERRREQE | 141 | Q96J92 |